This is different from an adverse drug reaction ... The CDC extended the emergency use authorization for the Pfizer-BioNTech Comirnaty vaccine in August 2024 to include the current 2024-25 formula.
Just days after its advisory committee meeting voted to approve a third dose of Pfizer ... of mixing different vaccines. Other countries, including the UK, have set out plans for booster campaigns ...
Unexpected demand for Pfizer Inc.’s Covid vaccine helped the company beat quarterly expectations. Then Robert F. Kennedy Jr., ...
In the fourth quarter, a larger-than-expected sales haul of $4.1 billion from Pfizer's COVID vaccine Cominaty and its antiviral Paxlovid helped drive the company’s total revenue of $17.8 billion ...
Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's nomination moved forward. © 2024 Fortune ...
Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Should Big Pharma be worried? Analysts believe it bodes poorly for vaccine makers. But Pfizer (PFE) CEO Albert Bourla said he doesn't think so, in an interview with Yahoo Finance. In fact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback